PremiumMLYS

Unusual volume of purchases

At MLYS, which went public about two years ago and develops new treatments for diseases in the body, three significant insider trades were reported, which may hint at something big brewing.

By the SpyStocks desk · 1y ago · 1 min read

Related Stories

Major move at Somnigroup International: CEO buys shares for almost $2 million one day after major deal completion

PremiumInsidersSGI8h ago3 min read

Will Pfizer do a Moderna for investors?

PremiumInsidersPFE1d ago4 min read

Intriguing activity in Madison Air

PremiumInsidersMAIR1d ago3 min read